Can Botox Clear Your Skin? Acne, Oil and Pores Explained

Regular Botox, microbotox and a “Botox facial” are different proposals

When someone says their skin looks better after Botox, they may mean fewer forehead creases, less shine, smoother-looking cheeks or fewer pimples. Those changes do not necessarily come from the same procedure.

Standard wrinkle treatment targets selected muscles. Botox Cosmetic reduces a nerve signal that makes those muscles contract. The skin folds less strongly over them. For the treatment experience, brand differences and routine upkeep, start with our Botox beginner guide.

Intradermal treatment places toxin within the skin. “Microbotox,” “microtoxin” and “skin Botox” commonly describe approaches using small, superficial deposits. Researchers have studied these approaches for oil, pores and texture. The names do not establish one standardized formula, treatment area or result: studies use different products and methods. Sayed et al.; Sapra et al.

A microneedling device being cleared for a particular skin treatment does not establish that a toxin-containing cocktail is cleared too. FDA says microneedling devices are not approved to deliver drugs and other products into skin. This is a reason to ask exactly what is proposed, not to assume every service called a facial is equivalent. FDA microneedling information.

How might botulinum toxin reduce oil and visible pores?

The oil on your skin is sebum, produced by sebaceous glands. It is different from sweat. Sebum helps protect skin, but excess oil and material collecting in follicles can contribute to acne. Inflammation is part of acne too; it is not simply a dirty or sweaty face. NIAMS: acne biology.

Laboratory research and a small human study found that acetylcholine signaling can influence oil-producing cells. That provides a biological reason for studying botulinum toxin, which interferes with that signaling. It does not tell us that every injection pattern will control acne or that more toxin will produce a better result. Li et al., sebaceous-gland study.

Pore appearance also depends on what is inside the follicle and the skin around it. Clogging, oiliness and reduced firmness can make pores more noticeable. Reducing one contributor may help their appearance without changing all the others. Dermatologists therefore also discuss acne control, gentle skincare and sun protection when the complaint is “large pores.” AAD: visible pores.

A practical example: if your forehead creases soften but you still develop jawline breakouts, the wrinkle treatment may have achieved its goal. That does not mean it failed as Botox, or that you need a higher dose to treat the acne. You need the acne evaluated on its own terms.

What do the clinical studies actually show?

The evidence is growing, and the findings are mixed. There are positive oil and pore studies, a newer placebo-controlled acne trial, and trials that found little or no benefit for some of the same measurements. The treatment area, technique and outcome being measured help explain why a single “success rate” would mislead.

The older literature also includes a 10-person study that found texture improvement without a significant change in oil or pores. A 2024 systematic review pooled ten studies with 153 participants and found encouraging signals, but its additional analysis indicated that the evidence had not reached the amount needed for firm conclusions. Its search ended in March 2023, so it cannot summarize the 2025 and 2026 studies above. 2017 pilot trial; 2024 review.

These are studies of several botulinum toxin products. “Botox” is often used as a category nickname, but it is also a specific brand. The evidence does not establish that every brand, dose and method produces identical skin results. Our Botox versus Dysport guide explains why product names and units matter.

Is Botox a good treatment for acne?

It is an emerging option to discuss in a medical assessment, rather than the usual first purchase for breakouts. The American Academy of Dermatology’s 2024 guideline recommends established treatments including benzoyl peroxide and topical retinoids, with prescription options for the person’s severity and circumstances. Botulinum toxin is not among its recommended acne treatments. That guideline predates the 2026 trial, so its omission does not dismiss the newer finding. AAD acne guideline.

A sensible plan starts with the kind of acne you have, what you have already tried, how consistently you could use it and whether scarring is developing. Repeatedly switching products after a few days can make it difficult to judge the response. For many over-the-counter acne approaches, AAD advises allowing six to eight weeks before evaluating improvement; deep or painful acne warrants earlier professional care. AAD: treating different acne types.

Topical retinoids are not all the same purchase. Adapalene is an acne medicine; cosmetic retinol has a different label and evidence base. Our retinol and retinoid buying guide explains the distinction. Pregnancy, plans for pregnancy and breastfeeding change which treatments are appropriate, so review those before starting a new acne routine.

What about texture, acne scars, red marks and collagen?

Improvement in “skin quality” is not one outcome. A study can find smoother-looking skin without demonstrating fewer pimples, less pigmentation or repair of indented scars. Ask which change the procedure is supposed to produce.

Indented scars need a scar-specific assessment

A pore, a flat mark after a pimple and a depressed acne scar can look similar in a small photograph. They need different treatment choices. AAD describes scar care that depends on scar type, skin tone and other factors, often after active acne is controlled. Options can include selected resurfacing procedures, microneedling or scar surgery; that is not a menu to combine without assessment. AAD: acne-scar treatment.

Some toxin studies combine it with another intervention. For example, a 16-person trial compared two hyaluronic-acid-and-toxin approaches for atrophic acne scars. Because both groups received combinations, it cannot tell a reader how much scar improvement toxin alone would provide. 2024 combination trial. Our skin texture guide helps separate scars, pores and other causes of an uneven surface.

Red marks are another research question

A 2025 split-face study of 30 people compared toxin with broadband light for redness left after acne, following participants for three months. That is early evidence about post-acne redness, not a finding that Botox treats every dark spot or replaces active acne care. Flat brown marks, persistent redness and new breakouts should not be grouped together under a promise to “clear skin.” Post-acne erythema trial.

Does Botox build collagen?

A 2015 study followed 48 women, with 43 completing follow-up, and measured changes in how skin stretched and recoiled after onabotulinumtoxinA. It found temporary changes in skin mechanics. It did not directly establish new collagen production as the explanation, and the mechanism remained uncertain. “Improved elasticity” should therefore not be rewritten as “proven collagen rebuilding.” Bonaparte and Ellis.

If your main concern is a crease that remains when your face is relaxed, compare its depth and cause with our fine-lines and wrinkles guide. For sun damage or a scar-treatment proposal, the skin treatment comparison is a better next step than assuming additional toxin treats every kind of texture.

How soon could skin improve, and how long might it last?

Expect a temporary effect if you respond, not a permanent change in your pores or acne tendency. The early oily-forehead study detected changes from one week through three months. The 2021 cheek study assessed participants at one and four months. These are study observation points, not a personalized schedule. Oily-forehead study; Cheek study.

Another randomized forehead study found that oil production returned to baseline by 16 weeks. A higher studied amount did not extend that duration. This argues against treating “more units” as an automatic solution when the goal is less shine. Min et al., 2015.

Agree on what improvement would look like

Before treatment, choose one main outcome: less midday shine, fewer new acne lesions, less noticeable pores or softer expression lines. A clinician may track several, but you should know which matters most to you.

• Use comparable photographs: similar lighting, camera distance, expression and makeup conditions.
• Record other changes: a new retinoid, peel or prescription may also affect what you see.
• Choose a review date: agree when to assess the result and how to report an unwanted effect sooner.
• Set a stopping rule: if the benefit is too small for the cost or side effects, discuss changing the plan rather than automatically buying another session.

These are practical ways to make your own treatment review more useful. They do not turn a home photograph into a clinical trial. A clinic’s before-and-after gallery should also identify timing and any combined procedures; a brightly lit after-photo alone cannot tell you what toxin contributed.

What are the risks of superficial Botox for skin?

“Micro” describes an approach, not a guarantee of minor risk. Needle-site pain, redness, swelling or bruising can occur. Unwanted weakness may change facial movement; the cheek study above reported a case of facial weakness. A small study reporting few complications cannot establish that a procedure is risk-free. MedlinePlus drug information; Shin et al.

Before deciding, disclose pregnancy or breastfeeding, previous toxin reactions, facial weakness, eye or face surgery, all medicines and supplements, and any recent botulinum toxin treatment. An infected injection site is a reason not to inject there. The clinician needs to review your history and the actual area being treated. Preparation precautions. Our Botox suitability guide goes further into that conversation.

Choose a qualified medical clinician who can explain the proposed use and manage a complication. Avoid online toxin purchases and injections in nonmedical settings. A consultation can end with a skincare or acne plan and no injections. AAD safety guidance; how to evaluate a provider.

Is paying for a Botox facial or pore treatment worth it?

It depends on whether the likely change is worth the complete repeat-treatment cost to you. “Microbotox” does not identify one standardized package. A quote may include different areas, products, devices or additional procedures, so compare the written contents before comparing the headline price.

Our Botox cost guide explains unit-based and area-based quotes. Do not treat its ordinary wrinkle-treatment examples as a verified market price for an intradermal skin-quality service.

Five questions worth getting answered before you pay

1. What are we treating? Oil, pore appearance, active acne, redness, a scar or an expression line?
2. What will you use and how? Get the product name and whether the proposal involves muscle injections, intradermal injections or a device-assisted combination.
3. What evidence matches my goal? Ask for a relevant outcome, not just evidence that the brand treats wrinkles.
4. What happens if I respond poorly? Know who handles unwanted weakness, skin reactions and follow-up.
5. What is the complete plan and price? Separate today’s appointment, optional add-ons, a results review and future treatments.

If the explanation stays at “glass skin” or “poreless,” bring it back to a visible change you can evaluate. You do not have to buy a series to justify asking those questions.

Frequently asked questions

Sources and editorial notes

Research and US labeling checked October 10, 2026. Prepared by NuWays MD; edited by Darryl H. Clinical review is pending. This is educational information, not a diagnosis or individualized treatment plan. We reviewed the primary sources below and selected guidance from FDA, NIH and the American Academy of Dermatology. This is an editorial evidence review, not a systematic review or original clinical study.

Several papers were available as abstracts and publisher summaries rather than full text, including the 2025 acne study and 2026 placebo-controlled acne trial. Their summaries support the results described here but do not provide a complete assessment of detailed methods or adverse events. The 2022 cheek study’s product correction is included. The $400 example and original diagram are explanatory, not patient results or price research.

Regulatory information and clinical guidance

• Botox Cosmetic prescribing information. Approved uses, product-specific units and boxed warning; revised October 2024 in the copy reviewed.
• FDA: understanding off-label use. What an approved drug’s unapproved use means.
• FDA: microneedling devices. Device authorization does not establish approval to deliver a drug cocktail.
• AAD 2024 acne guideline, types of acne, visible pores and acne-scar treatment. Standard care and the distinction between active lesions, pores and scars.
• NIAMS acne overview. Follicles, oil and inflammation.
• MedlinePlus: onabotulinumtoxinA and AAD toxin FAQs. Preparation, adverse effects and provider-setting considerations.

Clinical research

• Li et al., 2013. Acetylcholine signaling in oil-producing cells and a small human investigation.
• Rose and Goldberg, 2013. Oily-forehead treatment in 25 patients.
• Min et al., 2015. Randomized forehead study of oil changes and duration.
• Bonaparte and Ellis, 2015. Skin mechanics after treatment, not direct proof of collagen production.
• Sapra et al., 2017. Ten-person pilot with differing texture, pore and oil outcomes.
• Sayed et al., 2021 print publication. Twenty-person saline-controlled cheek study; first published online in January 2020.
• Shin et al., 2022 and 2023 corrigendum. Cheek outcomes and correction identifying Coretox. The authors disclosed manufacturer research funding.
• 2024 systematic review and meta-analysis. Ten studies, 153 participants; search through March 2023.
• Behrangi et al., 2024. Sixteen-person scar study comparing combination treatments.
• Elshabory et al., 2025. Thirty-person acne study; abstract and publisher information reviewed.
• Yang et al., 2025. Thirty-person study of redness after acne.
• Rungtiravatananon et al., 2026. Seventy-five-person placebo-controlled forehead acne trial; abstract and publisher information reviewed. The authors reported university funding and donated toxin from Daewoong Pharmaceutical.
• Dominguez-Salgado et al., July 2026. Thirty-person cheek study with six-week follow-up.